vs
PARK NATIONAL CORP（PRK）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是PARK NATIONAL CORP的1.2倍（$197.9M vs $168.3M），PARK NATIONAL CORP净利率更高（25.3% vs 6.7%，领先18.6%），REPLIGEN CORP同比增速更快（13.6% vs 2.2%），PARK NATIONAL CORP自由现金流更多（$191.9M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 4.9%）
国家零售系统公司（NRS）旗下包含基石货运公司与国家零售运输公司，是一家成立于1952年的资产型第三方物流服务商，总部位于美国新泽西州林德赫斯特，为客户提供专业的物流供应链相关解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
PRK vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.2倍
$168.3M
营收增速更快
RGEN
高出11.5%
2.2%
净利率更高
PRK
高出18.6%
6.7%
自由现金流更多
PRK
多$174.4M
$17.6M
两年增速更快
RGEN
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.3M | $197.9M |
| 净利润 | $42.6M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | — | 9.0% |
| 净利率 | 25.3% | 6.7% |
| 营收同比 | 2.2% | 13.6% |
| 净利润同比 | 10.4% | 143.9% |
| 每股收益（稀释后） | $2.62 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PRKRGEN
| Q4 25 | $168.3M | $197.9M | ||
| Q3 25 | $169.5M | $188.8M | ||
| Q2 25 | $168.7M | $182.4M | ||
| Q1 25 | $157.9M | $169.2M | ||
| Q4 24 | $164.7M | $174.1M | ||
| Q3 24 | $170.3M | $154.9M | ||
| Q2 24 | $157.7M | $154.1M | ||
| Q1 24 | $152.8M | $151.3M |
净利润PRKRGEN
| Q4 25 | $42.6M | $13.3M | ||
| Q3 25 | $47.2M | $14.9M | ||
| Q2 25 | $48.1M | $14.9M | ||
| Q1 25 | $42.2M | $5.8M | ||
| Q4 24 | $38.6M | $-30.3M | ||
| Q3 24 | $38.2M | $-654.0K | ||
| Q2 24 | $39.4M | $3.3M | ||
| Q1 24 | $35.2M | $2.1M |
毛利率PRKRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率PRKRGEN
| Q4 25 | — | 9.0% | ||
| Q3 25 | 34.3% | 8.9% | ||
| Q2 25 | 35.2% | 7.6% | ||
| Q1 25 | 32.4% | 3.9% | ||
| Q4 24 | — | -17.7% | ||
| Q3 24 | 27.4% | -5.1% | ||
| Q2 24 | 30.6% | 1.0% | ||
| Q1 24 | 27.8% | 1.3% |
净利率PRKRGEN
| Q4 25 | 25.3% | 6.7% | ||
| Q3 25 | 27.8% | 7.9% | ||
| Q2 25 | 28.5% | 8.2% | ||
| Q1 25 | 26.7% | 3.4% | ||
| Q4 24 | 23.5% | -17.4% | ||
| Q3 24 | 22.4% | -0.4% | ||
| Q2 24 | 25.0% | 2.2% | ||
| Q1 24 | 23.0% | 1.4% |
每股收益（稀释后）PRKRGEN
| Q4 25 | $2.62 | $0.24 | ||
| Q3 25 | $2.92 | $0.26 | ||
| Q2 25 | $2.97 | $0.26 | ||
| Q1 25 | $2.60 | $0.10 | ||
| Q4 24 | $2.38 | $-0.55 | ||
| Q3 24 | $2.35 | $-0.01 | ||
| Q2 24 | $2.42 | $0.06 | ||
| Q1 24 | $2.17 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $233.5M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.4B | $2.1B |
| 总资产 | $9.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资PRKRGEN
| Q4 25 | $233.5M | $767.6M | ||
| Q3 25 | $218.9M | $748.7M | ||
| Q2 25 | $193.1M | $708.9M | ||
| Q1 25 | $237.6M | $697.2M | ||
| Q4 24 | $160.6M | $757.4M | ||
| Q3 24 | $201.7M | $784.0M | ||
| Q2 24 | $261.5M | $809.1M | ||
| Q1 24 | $306.1M | $780.6M |
总债务PRKRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益PRKRGEN
| Q4 25 | $1.4B | $2.1B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.3B | $2.0B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B | ||
| Q1 24 | $1.2B | $2.0B |
总资产PRKRGEN
| Q4 25 | $9.8B | $2.9B | ||
| Q3 25 | $9.9B | $2.9B | ||
| Q2 25 | $9.9B | $2.9B | ||
| Q1 25 | $9.9B | $2.9B | ||
| Q4 24 | $9.8B | $2.8B | ||
| Q3 24 | $9.9B | $2.8B | ||
| Q2 24 | $9.9B | $2.9B | ||
| Q1 24 | $9.9B | $2.8B |
负债/权益比PRKRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $191.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 114.1% | 8.9% |
| 资本支出强度资本支出/营收 | 3.8% | 4.1% |
| 现金转化率经营现金流/净利润 | 4.65× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $328.2M | $93.9M |
8季度趋势，按日历期对齐
经营现金流PRKRGEN
| Q4 25 | $198.3M | $25.7M | ||
| Q3 25 | $52.6M | $48.1M | ||
| Q2 25 | $49.7M | $28.6M | ||
| Q1 25 | $37.9M | $15.0M | ||
| Q4 24 | $178.8M | $39.2M | ||
| Q3 24 | $43.8M | $49.3M | ||
| Q2 24 | $50.9M | $42.2M | ||
| Q1 24 | $35.0M | $44.7M |
自由现金流PRKRGEN
| Q4 25 | $191.9M | $17.6M | ||
| Q3 25 | $51.1M | $43.4M | ||
| Q2 25 | $48.4M | $21.5M | ||
| Q1 25 | $36.8M | $11.4M | ||
| Q4 24 | $169.7M | $33.6M | ||
| Q3 24 | $41.7M | $42.3M | ||
| Q2 24 | $49.0M | $37.4M | ||
| Q1 24 | $31.9M | $36.4M |
自由现金流率PRKRGEN
| Q4 25 | 114.1% | 8.9% | ||
| Q3 25 | 30.1% | 23.0% | ||
| Q2 25 | 28.7% | 11.8% | ||
| Q1 25 | 23.3% | 6.8% | ||
| Q4 24 | 103.0% | 19.3% | ||
| Q3 24 | 24.5% | 27.3% | ||
| Q2 24 | 31.1% | 24.3% | ||
| Q1 24 | 20.8% | 24.0% |
资本支出强度PRKRGEN
| Q4 25 | 3.8% | 4.1% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 0.8% | 3.9% | ||
| Q1 25 | 0.7% | 2.1% | ||
| Q4 24 | 5.6% | 3.2% | ||
| Q3 24 | 1.2% | 4.5% | ||
| Q2 24 | 1.2% | 3.1% | ||
| Q1 24 | 2.1% | 5.5% |
现金转化率PRKRGEN
| Q4 25 | 4.65× | 1.93× | ||
| Q3 25 | 1.11× | 3.23× | ||
| Q2 25 | 1.03× | 1.92× | ||
| Q1 25 | 0.90× | 2.57× | ||
| Q4 24 | 4.63× | — | ||
| Q3 24 | 1.14× | — | ||
| Q2 24 | 1.29× | 12.70× | ||
| Q1 24 | 0.99× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
